Elevance Health Inc. (ELV) Tops Q2 EPS by 25c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Elevance Health Reports Second Quarter 2023 Results
July 19, 2023 6:00 AM EDTSecond quarter GAAP net income was $7.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $9.04* per share. Operating revenue grew 12.7% year-over-year to $43.4 billion Operating gain grew 12.0% year-over-year to $2.6 billion Medical enrollment increased 938 thousand members year-over-year to 48.0 million members Third quarter 2023 dividend of $1.48 per share declared to shareholders
INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health, Inc. (NYSE: ELV) reported second quarter 2023 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and... More



